Correlation between enhanced intensity of atherosclerotic plaque at contrast-enhanced ultrasonography and density of histological neovascularization

Abstract

The feasibility of contrast-enhanced ultrasonography in the assessment of atherosclerotic plaque neovascularization and its relation to histological findings were investigated. Abdominal aortic atherosclerotic plaque model was induced in 25 New Zealand white rabbits by a combination of high cholesterol-rich diet and balloon aortic denudation. Standard and contrast-enhanced ultrasonography was performed at the 16th week of the model induction period. The plaques were classified as echogenic plaques or echolucent plaques according to their echogenicity at standard ultrasonography. The maximum thickness of plaque was measured in the longitudinal section. Time intensity curve was used to quantify the enhanced intensity of the plaque. Animals were euthanized and abdominal aortas were harvested for histological staining of CD31 to evaluate the neovascularization density of atherosclerotic plaque. The results showed that the echolucent plaques had higher enhanced intensity during contrastenhanced ultrasonography and higher neovascularization density at CD31 staining than the echogenic plaques. The enhanced intensity of atherosclerotic plaque and its ratio to lumen were well correlated with histological neovascularization density (r=0.75, P<0.001; r=0.68, P<0.001, respectively). However, the maximum thickness of plaque was not correlated with neovascularization density (r=0.235, P=0.081). These findings demonstrated that the enhanced intensity in the plaque and ratio of enhanced intensity to that in the lumen of abdominal aorta may be more accurate in the evaluation of plaque neovascularization than maximum thickness. Our study indicates that contrast-enhanced ultrasonography provides us a reliable method for the evaluation of plaque neovascularization.

Keywords

contrast-enhanced ultrasonography / plaque / enhanced intensity / histopathological correlation

References

[1] FordES, CapewellS. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol, 2007, 50(22): 2128-2132

[2] ShalhoubJ, OwenDR, GauthierT, et al.. The use of contrast enhanced ultrasound in carotid arterial disease. Eur J Vasc Endovasc Surg, 2010, 39(4): 381-387

[3] StaubD, PatelMB, TibrewalaA, et al.. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke, 2010, 41(1): 41-47

[4] CarlierS, KakadiarisIA, DibN, et al.. Vasa vasorum imaging: a new window to the clinical detection of vulnerable atherosclerotic plaques. Curr Atheroscler Rep, 2005, 7(2): 164-169

[5] ColiS, MagnoniM, SangiorgiG, et al.. Contrast-enhanced ultrasound imaging in intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol, 2008, 52(3): 223-230

[6] StaubD, PartoviS, SchinkelAF, et al.. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology, 2011, 258(2): 618-626

[7] DunmoreBJ, McCarthyMJ, NaylorAR, et al.. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg, 2007, 45(1): 155-159

[8] MorenoPR, PurushothamanKR, SirolM, et al.. Neovascularization in human atherosclerosis. Circulation, 2006, 113(18): 2245-2252

[9] StaubD, SchinkelAF, CollB, et al.. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging, 2010, 3(7): 761-771

[10] XiongL, DengYB, ZhuY, et al.. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology, 2009, 251(2): 583-589

[11] KoutouzisM, NomikosA, NikolidakisS, et al.. Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. Atherosclerosis, 2007, 192(2): 455-456

[12] FeinsteinSB, CollB, StaubD, et al.. Contrast enhanced ultrasound imaging. J Nucl Cardiol, 2010, 17(1): 106-115

[13] ArmstrongWF, RyanT. Feigenbaum’s Echocardiography. Philadelphia: Lippincott Williams & Wilkins, 201067-89

[14] VicenziniE, GiannoniMF, PuccinelliF, et al.. Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent. Stroke, 2007, 38(10): 2841-2843

[15] FeinsteinSB. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol, 2004, 287(2): 451-457

[16] HoogiA, AdamD, HoffmanA, et al.. Carotid plaque vulnerability: quantification of neovascularization on contrast-enhanced ultrasound with histopathologic correlation. Am J Roentgenol, 2011, 196(2): 431-436

[17] CortiR, OsendeJ, HutterR, et al.. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis, 2007, 190(1): 106-113